Pre-Clinical Lessons We Wish We’d Known

Resources

Pre-Clinical Lessons We Wish We’d Known

Topic: Webinar

What seasoned medtech developers would do differently — and why it matters

Pre-clinical studies and early-stage trials are some of the most challenging — and expensive — milestones in medical device development. Yet, many teams encounter avoidable setbacks that could have been prevented with strategic foresight and practical lessons learned from experience.

In the webinar “Pre-Clinical Lessons We Wish We’d Known,” three experienced medtech professionals — Joris van der Heijden (Concept Development Lead), Paul Hulme (Human Factors Engineer), and Nick Allan (Bio Services Manager) from StarFish Medical — share candid stories, real-world challenges, and the pivotal pre-clinical insights they’ve gained over decades of medical device development.

Key Takeaways from the Webinar:

  • Design with the drug container in mind — Why selecting or accommodating the right primary drug container is critical for pharma partnerships and market acceptance.
  • Minimizing use errors through user-centered design — How real-world user behavior and stress conditions impact device performance, and why early usability testing is essential.
  • Lessons in IFU reliance and training — Why you can’t count on users reading instructions, and how hands-on training and competency checks can mitigate risk.
  • Packaging and labeling pitfalls — Surprising findings on what users actually notice on packaging (and what they don’t) and how simple design changes can improve safety and compliance.
  • The risks of last-minute design changes before trials — A cautionary story from clinical research where small hardware adjustments led to major setbacks.
  • Pre-clinical validation strategies that work — How simulation models, imaging studies, and stepwise testing can reduce uncertainty before entering costly clinical trials.

Whether you’re an engineer, program manager, clinical lead, or regulatory professional, this webinar offers practical, hard-earned advice to help you avoid delays, reduce risk, and position your medical device for clinical and market success.

Speakers

  • Joris van der Heijden, Concept Development Lead, StarFish Medical
  • Paul Hulme, Human Factors Engineer, StarFish Medical
  • Nick Allan, Bio Services Manager, StarFish Medical

Pre-Clinical Lessons We Wish We’d Known

Insights to help you avoid costly mistakes — before clinical trials begin.

Watch the recording
Gloved hand holds fluorescent liquid over a UV-lit surface with green glow and red arrow pointing to the light, captioned ‘See the Clean?

Fluorescent Soil Load Test

Nick Allan and Nigel Syrotuck explore a creative approach to visualizing cleaning validation using a fluorescent soil load.

Gloved hands insert a swab into a sealed vial beside a crossed-out O₂ symbol with the text “No Oxygen Allowed?” illustrating anaerobic sample collection.

Anaerobic Sample Collection Explained

Nick Allan joins Nigel Syrotuck to explore how anaerobic sample collection works and why it’s vital for studying bacteria that cannot survive in oxygen.

icons representing different medical device classes

Difference Between Class 1, 2, and 3 Medical Devices

Understanding medical device classifications is critical for compliance, risk management, and time-to-market success. Whether you’re designing a wearable sensor or a life-sustaining implant, knowing how your device fits into FDA Class 1, 2, or 3 categories is essential.

Targeted Drug Delivery Infographic

Delivering a drug to the right place at the right time can define the success of a therapy. Yet understanding delivery routes, devices, and technologies across the body can be complex.